Literature DB >> 8939934

Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation.

T A Tai1, C Jennermann, K K Brown, B B Oliver, M A MacGinnitie, W O Wilkison, H R Brown, J M Lehmann, S A Kliewer, D C Morris, R A Graves.   

Abstract

Brown adipose tissue (BAT) functions in non-shivering and diet-induced thermogenesis via its capacity for uncoupled mitochondrial respiration. BAT dysfunction in rodents is associated with severe defects in energy homeostasis, resulting in obesity and hyperglycemia. Here, we report that the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma), a prostaglandin-activated transcription factor recently implicated as a central regulator of white adipose tissue differentiation, also regulates brown adipocyte function. PPARgamma is abundantly expressed in both embryonic and adult BAT. Treatment of CD-1 rats with the PPARgamma-selective ligand BRL49653, an anti-diabetic drug of the thiazolidinedione class, results in marked increases in the mass of interscapular BAT. In vitro, BRL49653 induces the terminal differentiation of the brown preadipocyte cell line HIB-1B as judged by both changes in cell morphology and expression of uncoupling protein and other adipocyte-specific mRNAs. These data demonstrate that PPARgamma is a key regulatory factor in brown adipocytes and suggest that PPARgamma functions not only in the storage of excess energy in white adipose tissue but also in its dissipation in BAT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939934     DOI: 10.1074/jbc.271.47.29909

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Molecular mechanisms of adipocyte differentiation.

Authors:  Q Tong; G S Hotamisligil
Journal:  Rev Endocr Metab Disord       Date:  2001-10       Impact factor: 6.514

2.  PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein.

Authors:  Haruya Ohno; Kosaku Shinoda; Bruce M Spiegelman; Shingo Kajimura
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

3.  PRDM16 represses the type I interferon response in adipocytes to promote mitochondrial and thermogenic programing.

Authors:  Megan Kissig; Jeff Ishibashi; Matthew J Harms; Hee-Woong Lim; Rachel R Stine; Kyoung-Jae Won; Patrick Seale
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

4.  Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure.

Authors:  Daozhong Jin; Hong Guo; So Young Bu; Yuanyuan Zhang; Jennifer Hannaford; Douglas G Mashek; Xiaoli Chen
Journal:  FASEB J       Date:  2010-10-25       Impact factor: 5.191

Review 5.  Brown and beige fat: development, function and therapeutic potential.

Authors:  Matthew Harms; Patrick Seale
Journal:  Nat Med       Date:  2013-09-29       Impact factor: 53.440

6.  Isolation and differentiation of stromal vascular cells to beige/brite cells.

Authors:  Ulrike Liisberg Aune; Lauren Ruiz; Shingo Kajimura
Journal:  J Vis Exp       Date:  2013-03-28       Impact factor: 1.355

Review 7.  Regulatory circuits controlling white versus brown adipocyte differentiation.

Authors:  Jacob B Hansen; Karsten Kristiansen
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

Review 8.  Non-sympathetic control of brown adipose tissue.

Authors:  R Cereijo; J Villarroya; F Villarroya
Journal:  Int J Obes Suppl       Date:  2015-08-04

Review 9.  Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

Authors:  Antona J Wagstaff; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Bone is a target for the antidiabetic compound rosiglitazone.

Authors:  S O Rzonca; L J Suva; D Gaddy; D C Montague; B Lecka-Czernik
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.